海南橡膠(601118.SH):收到橡膠收入保險賠款3561.76萬元
格隆匯12月19日丨海南橡膠(601118.SH)公佈,根據海南天然橡膠產業集團股份有限公司與中國太平洋財產保險股份有限公司海南分公司、中國人民財產保險股份有限公司海南省分公司、中國人壽財產保險股份有限公司海南省分公司、中國平安財產保險股份有限公司海南分公司、陽光財產保險股份有限公司海南省分公司簽訂的《海南橡膠2023年橡膠收入保險項目保險協議》約定,2023年8月期間因價格波動觸發保險賠付條件,經查勘定損,確定保險賠付金額為35,617,601.12元。近日,公司已收到上述賠付款項,會計核算計入其他收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.